Skip to main content
×
×
Home

Antibiotic Use in Developing Countries

  • Raúl E. Istúriz (a1) and Claude Carbon (a1)
Abstract

Antimicrobials have been used successfully for over 6 decades, but genes expressing resistance to them have emerged in strains of bacteria and have disseminated through the global ecosystem to reach infecting microorganisms, produce disease, and seriously interfere with therapy, allowing infections to progress and kill despite antibiotic administration. The upsurge in prevalence of such resistance genes in the bacterial population that colonize and infect humans involves two processes, emergence and dissemination, in both of which there have been contributions from the developing world, where resistance is common and increasing. The emergence of pneumococcal isolates noted in Papua New Guinea and later in South Africa that 1 decade later spread to most of the world and the intercontinental spread between the United States and Venezuela of a new gentamicin resistance gene carried on an epidemic plasmid are examples of the ability of bacteria to travel freely, without regard to borders. Complex societal issues such as the misuse of antibiotics by physicians, pharmacists, and the public; the suboptimal quality of the drugs (emergence); and conditions such as crowding, lack of hygiene, poor or nonexistent hospital infection control practices, or insufficient surveillance (dissemination) play a largely unmeasured role that requires study and solutions. In the meantime, we may intervene to delay the emergence of resistance and to limit its spread by promoting the judicious use of antibiotics both at the local level as well as from multinational organized cooperative efforts. Education and improvement of surveillance and socioeconomic conditions are integral parts of any solution strategy.

Copyright
Corresponding author
Groupe Hospitaller Bichat-Claude Bernard, 46, rue Henri Huchard, 75877 Paris Cedex 18, France
References
Hide All
1. O'Brien TF. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. Clin Infect Dis 1997;24(suppl 1):S2S8.
2. Gwatkin DR, Guillot M. The Burden of Disease Among the Global Poor. Current Situation, Future Trends, and Implications for Strategy. Washington, DC: The World Bank; 2000. Health, Nutrition and Population Series.
3. World Health Organization. A review of world antibacterial consumption. Geneva, Switzerland: WHO. In press.
4. Col NF, O'Connor RW. Estimating worldwide current antibiotic usage: report of Task Force 1. Rev Infect Dis 1987;9(suppl 3):S232S243.
5. Okeke IN, Lamikanra A, Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis 1999;5:1827.
6. Hart CA, Kariuki S. Antimicrobial resistance in developing countries. BMJ 1998;317:647650.
7. World Health Organization. Public-Private Roles in the Pharmaceutical Sector. Implications for Equitable Access and Rational Drug Use. Health Economics and Drugs. DAP series no. 5; 1997:4565.
8. Hossain MM, Glass RI, Khan MR. Antibiotic use in a rural community in Bangladesh. Int J Epidemiol 1982;11:402405.
9. Sauerborn R, Ibrango I, Nougtara A, Borchert M, Hien M, Benzler J, et al. The economic cost of illness for rural households in Burkina Faso. Trap Med Parasitol 1995;46:5460.
10. Tudor SK, Amarasiri MW, Wijekoon TM. Access to Western drugs, medical pluralism, and choice of therapy in an urban, low income community of Sri Lanka. In: Etkin NL, Tan ML, eds. Medicines: Meaning and Context. Quezon City, Philippines: Health Action Information Network; 1994:185208.
11. World Health Organization. Containing Antimicrobial Resistance. WHO/CDS/CSR/DRS/99.2. Geneva, Switzerland: WHO; 1999. http://www.who.int/emc-documents/antimicrobial_resistance/docs/whocdscsrdrs992.pdf.
12. Guzman-Blanco MG, Casellas JM, Sader HS. Bacterial resistance to antimicrobial agents in Latin America. The giant is awakening. Infect Dis Clin North Am 2000;14:6782.
13. Galimand M, Guiyoule A, Gerbaud G, Rasoamanana B, Chanteau S, Carniel E, et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med 1997;337:677680.
14. Couper MR. Strategies for the rational use of antimicrobials. Clin Infect Dis 1997;24(suppl 1):S154S156.
15. Schwartz B. Preventing the spread of antimicrobial resistance among bacterial respiratory pathogens in industrialized countries. The case for judicious antimicrobial use. Clin Infect Dis 1999;28:211213.
16. Polk R. Optimal use of modern antibiotics: emerging trends. Clin Infect Dis 1999;29:264274.
17. Dowell SF, Marcy SS, Phillips WR, et al. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics 1998;101:163184.
18. Carbon C, Bax R. Regulating the use of antibiotics in the community. BMJ 1998;317:663665.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 19 *
Loading metrics...

Abstract views

Total abstract views: 478 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 18th January 2018. This data will be updated every 24 hours.